ONC BeiGene Ltd. Gross Return on Sales

ONC (BeiGene Oncology) - company brandmark

BeiGene Ltd is investing colossal funds into R&D to combat cancer, which drives its cost dynamics. This gross margin chart visualizes the effectiveness of this strategy, with the current figure standing at 87.40. The company is implementing eco-technologies in its laboratories while simultaneously scaling its workforce by recruiting leading global oncologists to expand the business.

Return on Gross Profit: beigene.com (ONC) for 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for BeiGene Corp (ONC)

- stock value and consensus price forecast:
Fundamental valuation:BeiGene Ltd.
Finished products of BeiGene Ltd.

Professional capital evaluates BeiGene Ltd (ONC) through the lens of direct cost management efficiency. The aggregate gross margin captures the profit share after deducting the cost of goods sold, reflecting the business's ability to adapt to rising expenses. The aggregate gross margin trend demonstrates how its status as a global leader in oncology enables the monetization of scientific innovations. The stability of this indicator confirms the high investment reliability of the asset.

Main competitors

Gross Profit Margin Halozyme Inc. (HALO)|Gross Profitability RevMed|Gross Return on Sales AAPG (Ascentage Pharma Group)|Gross Margin CGON|UroGen Pharma - Gross Return on Sales|Bicara Therapeutics - Return on Gross Profit|Gross Margin Personalis Inc PSNL|Erasca Oncology - Gross Margin|Gross Profit Rate DCTH (Delcath Corp)|YMAB: Gross Margin|AURA - Return on Sales by Gross Profit|CADL (Candel Therapeutics Inc.) - Gross Margin|Gross Return on Sales ARAY (Accuray)|Return on Gross Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Gross Profit Margin|Gross Profitability Citius Oncology, Inc. CTOR|HURA - Return on Gross Profit|protaratx.com - Gross Margin|FATE - Gross Margin|WHWK: Gross Margin|TScan Therapeutics (TCRX) - Gross Margin|Gross Profitability Champions Oncology|Gross Profitability XBIT|Gross Margin CVM|Return on Gross Profit OS Therapies Inc. OSTX|Gross Profitability Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Gross Profit Margin|ANL - Gross Profitability|Gross Profit Margin verupharma.com|TPST: Gross Margin|XLO - Return on Sales by Gross Profit|Gross Profitability Renovaro|Gross Margin muraloncology.com|Gross Margin KAPA|Return on Sales by Gross Profit OnKure Therapeutics, Inc.|Gross Margin GDTC (w2.cytomed.sg)|CRIS - Return on Gross Profit|Apollomics - Gross Margin|Tharimmune Corp (THAR) - Return on Gross Profit|ADVB: Gross Margin|Return on Gross Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Gross Margin|Gross Return on Sales SBFM (Sunshine Biopharma)|Gross Profitability Xenetic Bio (XBIO)|Gross Profitability SLRX (Salarius Pharma)|Kitov Pharma - Return on Gross Profit|American Oncology Network (AONC) - Gross Profit Margin|BeiGene - Gross Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Gross Profit|ELEV (Elevation Oncology, Inc.) - Return on Gross Profit|iCAD Inc. - Gross Profit Rate|Return on Gross Profit IKNA|Gross Margin notablelabs.com|Return on Gross Profit VIRX (Viracta Therapeutics Inc.)|MOR - Gross Profit Margin|Gross Profitability NAYA Biosciences NAYA|AAPGV - Return on Gross Profit